We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+9.73%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+561.69%
AUM
$492B
AUM Growth
+$21.5B
Cap. Flow
-$23.6B
Cap. Flow %
-4.79%
Top 10 Hldgs %
30.05%
Holding
13,811
New
1,370
Increased
4,863
Reduced
5,559
Closed
1,867

Sector Composition

Rank Sector Weight
1 Technology 2.7%
2 Consumer Discretionary 1.66%
3 Financials 1.18%
4 Communication Services 1.07%
5 Healthcare 0.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBBY
13651
DELISTED
Bed Bath & Beyond Inc
BBBY
-3,752,719
Closed -$1.6M
BBBY
13652
PUT
DELISTED
Bed Bath & Beyond Inc
BBBY
-3,569,600
Closed -$1.53M
FRC
13653
CALL
DELISTED
First Republic Bank
FRC
-3,754,200
Closed -$52.5M
FRC
13654
DELISTED
First Republic Bank
FRC
-1,315,003
Closed -$18.4M
FRC
13655
PUT
DELISTED
First Republic Bank
FRC
-6,063,700
Closed -$84.8M
OSH
13656
CALL
DELISTED
Oak Street Health, Inc.
OSH
-333,200
Closed -$12.9M
OSH
13657
DELISTED
Oak Street Health, Inc.
OSH
-303,297
Closed -$11.7M
OSH
13658
PUT
DELISTED
Oak Street Health, Inc.
OSH
-310,400
Closed -$12M
TRAQ.U
13659
DELISTED
Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant
TRAQ.U
-18,140
Closed -$190K
LMST
13660
DELISTED
Limestone Bancorp, Inc. Common Stock
LMST
-17,847
Closed -$398K
ORIA
13661
DELISTED
Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA
-10,006
Closed -$102K
PRVB
13662
CALL
DELISTED
Provention Bio, Inc. Common Stock
PRVB
-335,500
Closed -$8.09M
PRVB
13663
DELISTED
Provention Bio, Inc. Common Stock
PRVB
-363,758
Closed -$8.77M
PRVB
13664
PUT
DELISTED
Provention Bio, Inc. Common Stock
PRVB
-444,000
Closed -$10.7M
CSII
13665
CALL
DELISTED
Cardiovascular Systems, Inc.
CSII
-10,700
Closed -$213K
CSII
13666
DELISTED
Cardiovascular Systems, Inc.
CSII
-166,986
Closed -$3.32M
CSII
13667
PUT
DELISTED
Cardiovascular Systems, Inc.
CSII
-67,100
Closed -$1.33M
HZON
13668
DELISTED
Horizon Acquisition Corporation II
HZON
-43,579
Closed -$437K
HZON.WS
13669
DELISTED
Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HZON.WS
-33,333
Closed -$15.7K
AMBC.WS
13670
DELISTED
Ambac Financial Group
AMBC.WS
-40,000
Closed -$5.12K
BMAQR
13671
DELISTED
Blockchain Moon Acquisition Corp. Rights
BMAQR
-17,355
Closed -$911
BMAQW
13672
DELISTED
Blockchain Moon Acquisition Corp. Warrants
BMAQW
-55,350
Closed -$1.04K
IPVIW
13673
DELISTED
InterPrivate IV InfraTech Partners Inc. Warrant
IPVIW
-17,947
Closed -$1.61K
ALTIW
13674
DELISTED
AlTi Global Inc Warrant
ALTIW
-16,666
Closed -$18.7K
ML
13675
DELISTED
MoneyLion Inc.
ML
-2,212
Closed -$37.7K

Similar funds

Jeff Yass's Q2 2023 Portfolio in Review

As of Q2 2023, Jeff Yass held 13,811 positions worth $492B, up 4.6% from $470B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass withdrew a net $23.6B in Q2 2023, closing 1,867 positions and reducing 5,559 holdings. Its most notable exit was Vanguard Intermediate-Term Corporate Bond ETF, an estimated $45.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, up from 2.3% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Jeff Yass opened a new position in State Street SPDR Portfolio Aggregate Bond ETF worth $32.9M.

  • Jeff Yass's largest Q2 2023 buy was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M.
  • Jeff Yass added most to NVIDIA in Q2 2023, an estimated $1.79B increase.
  • Jeff Yass's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $2.48B.
  • Jeff Yass fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q2 2023, selling an estimated $45.5M.
  • Jeff Yass's ten largest holdings make up 30% of its $492B portfolio in Q2 2023.
  • Jeff Yass opened 1,370 new positions and closed 1,867 in Q2 2023.
  • Jeff Yass's portfolio value rose 4.6% quarter-over-quarter to $492B.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.